These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1295 related articles for article (PubMed ID: 16888910)

  • 21. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
    Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
    J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Significance of chromosome 9 alterations as an initial step in urothelial carcinogenesis].
    Habuchi T; Kato T; Takahashi T; Ogawa O
    Hinyokika Kiyo; 2000 Oct; 46(10):749-55. PubMed ID: 11215205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting.
    Gupta R; Paner GP; Amin MB
    Adv Anat Pathol; 2008 May; 15(3):127-39. PubMed ID: 18434765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract].
    Burger M; Catto J; van Oers J; Zwarthoff E; Hamdy FC; Meuth M; Azzouri AR; Cussenot O; Wild PJ; Stoehr R; Hartmann A
    Verh Dtsch Ges Pathol; 2006; 90():244-52. PubMed ID: 17867603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract.
    Phé V; Cussenot O; Rouprêt M
    BJU Int; 2009 Oct; 104(7):896-901. PubMed ID: 19522860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonal origin of lymph node metastases in bladder carcinoma.
    Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
    Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
    David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of denuded urothelium in papillary urothelial lesions.
    Owens CL; Epstein JI
    Am J Surg Pathol; 2007 Feb; 31(2):298-303. PubMed ID: 17255776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microsatellite instability in multifocal urothelial carcinoma and effect on BAX and AXIN2.
    Walsh AM; Bailly GG; Bell DG; Norman RW; Gupta R; Zayed E; Nassar BA
    Can J Urol; 2003 Oct; 10(5):2000-6. PubMed ID: 14633328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia.
    Lane Z; Epstein JI
    Am J Surg Pathol; 2008 May; 32(5):758-64. PubMed ID: 18379418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tract.
    Stoehr R; Brinkmann A; Filbeck T; Gamper C; Wild P; Blaszyk H; Hofstaedter F; Knuechel R; Hartmann A
    Oncol Rep; 2004 Jan; 11(1):137-41. PubMed ID: 14654916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract.
    Hafner C; Knuechel R; Zanardo L; Dietmaier W; Blaszyk H; Cheville J; Hofstaedter F; Hartmann A
    Oncogene; 2001 Aug; 20(35):4910-5. PubMed ID: 11521204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Precancerous lesions in the kidney.
    Van Poppel H; Nilsson S; Algaba F; Bergerheim U; Dal Cin P; Fleming S; Hellsten S; Kirkali Z; Klotz L; Lindblad P; Ljungberg B; Mulders P; Roskams T; Ross RK; Walker C; Wersäll P
    Scand J Urol Nephrol Suppl; 2000; (205):136-65. PubMed ID: 11144893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder.
    Hartmann A; Schlake G; Zaak D; Hungerhuber E; Hofstetter A; Hofstaedter F; Knuechel R
    Cancer Res; 2002 Feb; 62(3):809-18. PubMed ID: 11830537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearance.
    Catto JW; Hartmann A; Stoehr R; Bolderson E; Rehman I; Rosario DJ; Hamdy FC; Meuth M
    J Urol; 2006 Jun; 175(6):2323-30. PubMed ID: 16697867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF-betaRII, BAX, IGFIIR, caspase-5, hMSH3 and hMSH6 alterations are not associated with microsatellite instability or p53 mutations in invasive urothelial carcinoma of the urinary bladder.
    Saetta AA; Korkolopoulou P; Karlou M; Levidou G; Goudopoulou A; Thymara I; Stamatelli A; Tzivras M; Michalopoulos NV; Thomas-Tsagli E; Patsouris E
    Pathology; 2007 Aug; 39(4):425-32. PubMed ID: 17676485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of microsatellite instability determined by immunohistochemical staining of hMSH2 and hMSH6 in urothelial carcinoma of the bladder.
    Mylona E; Zarogiannos A; Nomikos A; Giannopoulou I; Nikolaou I; Zervas A; Nakopoulou L
    APMIS; 2008 Jan; 116(1):59-65. PubMed ID: 18254781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 mutations in multiple urothelial carcinomas: a molecular analysis of the development of multiple carcinomas.
    Goto K; Konomoto T; Hayashi K; Kinukawa N; Naito S; Kumazawa J; Tsuneyoshi M
    Mod Pathol; 1997 May; 10(5):428-37. PubMed ID: 9160306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Genetics of renal tumors].
    Oláh E; Jakab Z; Balogh E
    Orv Hetil; 2001 Jul; 142(26):1367-73. PubMed ID: 11478032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
    Catto JW; Azzouzi AR; Rehman I; Feeley KM; Cross SS; Amira N; Fromont G; Sibony M; Cussenot O; Meuth M; Hamdy FC
    J Clin Oncol; 2005 May; 23(13):2903-10. PubMed ID: 15753461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.